Serina Sandhu appointed to new global commercial director role

SunsolveMD by TheSolveMD has announced Serina Sandhu as its new global commercial director.

Formerly chief commercial officer at Aromatherapy Associates, Sandhu brings 16 years of experience in the cosmetics industry to the clinical SPF skincare brand.

SunsolveMD by TheSolveMD, launched in 2025, is a patented SPF-powered skincare system.

Formulated in Los Angeles and Copenhagen by a surgeon, a biomedical engineer and cosmetic chemist, it was developed to treat sun exposure as a clinical concern, rather than a cosmetic afterthought.

“My experience has been built around scaling businesses, leading high-performing teams, developing commercially successful growth strategies and driving operational excellence across complex global environments,” said Sandhu.

“What excites me most about joining SunsolveMD is the strength of the brand’s vision and the significant opportunity for international expansion.”

Leading global brand growth

Sandhu has experience across luxury beauty, wellness, retail and international distribution.

She has held senior roles at Voya Organic Beauty, Natura Bissé, Charlotte Tilbury Beauty and Shu Uemura.

At TheSolveMD, Sandhu will lead global commercial growth across all channels, while supporting the brand’s continued focus to bring innovative and industry-leading formulations to market.

Biotech meets luxury

SunsolveMD products are powered by SolveTech, the brand’s proprietary biotech platform.

The range contains SolveDNAReverse, a complex engineered to help defend skin DNA from UV mutation and oxidative damage.

Products target pigmentation, barrier damage and dermal resilience, and use a next-generation mineral delivery system to provide broad-spectrum protection that treats skin as it shields it.

Receive our newsletters directly to your inbox – sign up here